BerandaALKS • NASDAQ
add
Alkermes Plc
$29,52
Setelah Jam Perdagangan Normal:(0,00%)0,00
$29,52
Tutup: 5 Des, 20.00.00 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$29,30
Rentang hari
$28,97 - $29,59
Rentang tahun
$25,17 - $36,45
Kapitalisasi pasar
4,87Â M USD
Volume Rata-Rata
2,77Â jt
Rasio P/E
14,59
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 394,18Â jt | 4,24% |
Biaya operasional | 253,51Â jt | 20,55% |
Penghasilan bersih | 82,76Â jt | -10,41% |
Margin laba bersih | 21,00 | -14,04% |
Penghasilan per saham | 0,65 | -10,85% |
EBITDA | 97,16Â jt | -13,04% |
Tarif pajak efektif | 17,85% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,11Â M | 22,25% |
Total aset | 2,33Â M | 8,08% |
Total liabilitas | 596,08Â jt | -30,94% |
Total ekuitas | 1,73 M | — |
Saham yang beredar | 165,12 jt | — |
Harga terhadap nilai buku | 2,79 | — |
Tingkat pengembalian aset | 9,72% | — |
Tingkat pengembalian modal | 12,72% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 82,76Â jt | -10,41% |
Kas dari operasi | 101,67Â jt | 24,61% |
Kas dari investasi | -6,74Â jt | 93,84% |
Kas dari pembiayaan | 315,00Â rb | 100,28% |
Perubahan kas bersih | 95,25Â jt | 168,60% |
Arus kas bebas | 28,33Â jt | -10,74% |
Tentang
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Didirikan
1987
Situs
Karyawan
1.800
